Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 401

1.

Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.

Ziegler D, Strom A, Bönhof GJ, Kannenberg JM, Heier M, Rathmann W, Peters A, Meisinger C, Roden M, Thorand B, Herder C.

BMJ Open Diabetes Res Care. 2019 Nov 27;7(1):e000752. doi: 10.1136/bmjdrc-2019-000752. eCollection 2019.

2.

Association of longitudinal risk profile trajectory clusters with adipose tissue depots measured by magnetic resonance imaging.

Rospleszcz S, Lorbeer R, Storz C, Schlett CL, Meisinger C, Thorand B, Rathmann W, Bamberg F, Lieb W, Peters A.

Sci Rep. 2019 Nov 18;9(1):16972. doi: 10.1038/s41598-019-53546-y.

3.

A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy risk.

Kuss O, Rathmann W.

Acta Diabetol. 2019 Nov 6. doi: 10.1007/s00592-019-01440-4. [Epub ahead of print] No abstract available.

PMID:
31691868
4.

Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart.

Markus MRP, Rospleszcz S, Ittermann T, Baumeister SE, Schipf S, Siewert-Markus U, Lorbeer R, Storz C, Ptushkina V, Peters A, Meisinger C, Bamberg F, Nauck M, Bahls M, Völzke H, Felix SB, Bülow R, Rathmann W, Dörr M.

Cardiovasc Diabetol. 2019 Nov 4;18(1):145. doi: 10.1186/s12933-019-0948-4.

5.

Diabetes status affects long-term changes in coronal caries - The SHIP Study.

Schmolinsky J, Kocher T, Rathmann W, Völzke H, Pink C, Holtfreter B.

Sci Rep. 2019 Oct 30;9(1):15685. doi: 10.1038/s41598-019-51086-z.

6.

Serum uromodulin is inversely associated with the metabolic syndrome in the KORA F4 study.

Then C, Then H, Lechner A, Huth C, Meisinger C, Heier M, Peters A, Koenig W, Rathmann W, Herder C, Roden M, Scherberich J, Seissler J.

Endocr Connect. 2019 Sep 1. pii: EC-19-0352.R1. doi: 10.1530/EC-19-0352. [Epub ahead of print]

7.

Distinct trajectories of HbA1c in newly diagnosed Type 2 diabetes from the DPV registry using a longitudinal group-based modelling approach.

Rathmann W, Schwandt A, Hermann JM, Kuss O, Roden M, Laubner K, Best F, Ebner S, Plaumann M, Holl RW; DPV Initiative.

Diabet Med. 2019 Nov;36(11):1468-1477. doi: 10.1111/dme.14103. Epub 2019 Sep 23.

PMID:
31392761
8.

Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people.

Jacobs E, Rathmann W, Tönnies T, Arendt D, Marchowez M, Veith L, Kuss O, Brinks R, Hoyer A.

Diabet Med. 2019 Aug 7. doi: 10.1111/dme.14100. [Epub ahead of print]

PMID:
31390484
9.

Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance.

Wildberg C, Masuch A, Budde K, Kastenmüller G, Artati A, Rathmann W, Adamski J, Kocher T, Völzke H, Nauck M, Friedrich N, Pietzner M.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6357-6370. doi: 10.1210/jc.2019-01104.

PMID:
31390012
10.

Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.

Laxy M, Schöning VM, Kurz C, Holle R, Peters A, Meisinger C, Rathmann W, Mühlenbruch K, Kähm K.

Pharmacoeconomics. 2019 Dec;37(12):1485-1494. doi: 10.1007/s40273-019-00822-4.

PMID:
31350720
11.

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.

Zaharia OP, Strassburger K, Strom A, Bönhof GJ, Karusheva Y, Antoniou S, Bódis K, Markgraf DF, Burkart V, Müssig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer AFH, Kabisch S, Tselmin S, Häring HU, Ziegler D, Kuss O, Szendroedi J, Roden M; German Diabetes Study Group.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22.

PMID:
31345776
12.

Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes.

Ahn N, Baumeister SE, Amann U, Rathmann W, Peters A, Huth C, Thorand B, Meisinger C.

Sci Rep. 2019 Jul 4;9(1):9693. doi: 10.1038/s41598-019-46187-8.

13.

Genome-wide Association Study of Change in Fasting Glucose over time in 13,807 non-diabetic European Ancestry Individuals.

Liu CT, Merino J, Rybin D, DiCorpo D, Benke KS, Bragg-Gresham JL, Canouil M, Corre T, Grallert H, Isaacs A, Kutalik Z, Lahti J, Marullo L, Marzi C, Rasmussen-Torvik LJ, Rocheleau G, Rueedi R, Scapoli C, Verweij N, Vogelzangs N, Willems SM, Yengo L, Bakker SJL, Beilby J, Hui J, Kajantie E, Müller-Nurasyid M, Rathmann W, Balkau B, Bergmann S, Eriksson JG, Florez JC, Froguel P, Harris T, Hung J, James AL, Kavousi M, Miljkovic I, Musk AW, Palmer LJ, Peters A, Roussel R, van der Harst P, van Duijn CM, Vollenweider P, Barroso I, Prokopenko I, Dupuis J, Meigs JB, Bouatia-Naji N.

Sci Rep. 2019 Jul 1;9(1):9439. doi: 10.1038/s41598-019-45823-7.

14.

Persistent organic pollutants and the incidence of type 2 diabetes in the CARLA and KORA cohort studies.

Wolf K, Bongaerts BWC, Schneider A, Huth C, Meisinger C, Peters A, Schneider A, Wittsiepe J, Schramm KW, Greiser KH, Hartwig S, Kluttig A, Rathmann W.

Environ Int. 2019 Aug;129:221-228. doi: 10.1016/j.envint.2019.05.030. Epub 2019 May 24.

15.

Modifying effect of metabotype on diet-diabetes associations.

Riedl A, Wawro N, Gieger C, Meisinger C, Peters A, Rathmann W, Koenig W, Strauch K, Quante AS, Thorand B, Huth C, Daniel H, Hauner H, Linseisen J.

Eur J Nutr. 2019 May 14. doi: 10.1007/s00394-019-01988-5. [Epub ahead of print]

PMID:
31089867
16.

Helicobacter pylori Seropositivity: Prevalence, Associations, and the Impact on Incident Metabolic Diseases/Risk Factors in the Population-Based KORA Study.

Wawro N, Amann U, Butt J, Meisinger C, Akmatov MK, Pessler F, Peters A, Rathmann W, Kääb S, Waterboer T, Linseisen J.

Front Public Health. 2019 Apr 24;7:96. doi: 10.3389/fpubh.2019.00096. eCollection 2019.

17.

Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study.

Gomes MB, Rathmann W, Charbonnel B, Khunti K, Kosiborod M, Nicolucci A, Pocock SJ, Shestakova MV, Shimomura I, Tang F, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Ji L; DISCOVER investigators.

Diabetes Res Clin Pract. 2019 May;151:20-32. doi: 10.1016/j.diabres.2019.03.024. Epub 2019 Mar 20.

18.

Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4/FF4 study participants.

Then C, Then H, Meisinger C, Heier M, Peters A, Koenig W, Rathmann W, Scherberich J, Seissler J.

J Clin Endocrinol Metab. 2019 Mar 20. pii: jc.2018-02557. doi: 10.1210/jc.2018-02557. [Epub ahead of print]

PMID:
30892596
19.

Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion.

Gerards J, Heinrich DA, Adolf C, Meisinger C, Rathmann W, Sturm L, Nirschl N, Bidlingmaier M, Beuschlein F, Thorand B, Peters A, Reincke M, Roden M, Quinkler M.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3192-3202. doi: 10.1210/jc.2019-00299.

PMID:
30865224
20.

Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.

Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, Hofer E, Trompet S, Hilal S, Smith AV, Jian X, Malik R, Traylor M, Pulit SL, Amouyel P, Mazoyer B, Zhu YC, Kaffashian S, Schilling S, Beecham GW, Montine TJ, Schellenberg GD, Kjartansson O, Guðnason V, Knopman DS, Griswold ME, Windham BG, Gottesman RF, Mosley TH, Schmidt R, Saba Y, Schmidt H, Takeuchi F, Yamaguchi S, Nabika T, Kato N, Rajan KB, Aggarwal NT, De Jager PL, Evans DA, Psaty BM, Rotter JI, Rice K, Lopez OL, Liao J, Chen C, Cheng CY, Wong TY, Ikram MK, van der Lee SJ, Amin N, Chouraki V, DeStefano AL, Aparicio HJ, Romero JR, Maillard P, DeCarli C, Wardlaw JM, Hernández MDCV, Luciano M, Liewald D, Deary IJ, Starr JM, Bastin ME, Muñoz Maniega S, Slagboom PE, Beekman M, Deelen J, Uh HW, Lemmens R, Brodaty H, Wright MJ, Ames D, Boncoraglio GB, Hopewell JC, Beecham AH, Blanton SH, Wright CB, Sacco RL, Wen W, Thalamuthu A, Armstrong NJ, Chong E, Schofield PR, Kwok JB, van der Grond J, Stott DJ, Ford I, Jukema JW, Vernooij MW, Hofman A, Uitterlinden AG, van der Lugt A, Wittfeld K, Grabe HJ, Hosten N, von Sarnowski B, Völker U, Levi C, Jimenez-Conde J, Sharma P, Sudlow CLM, Rosand J, Woo D, Cole JW, Meschia JF, Slowik A, Thijs V, Lindgren A, Melander O, Grewal RP, Rundek T, Rexrode K, Rothwell PM, Arnett DK, Jern C, Johnson JA, Benavente OR, Wasssertheil-Smoller S, Lee JM, Wong Q, Mitchell BD, Rich SS, McArdle PF, Geerlings MI, van der Graaf Y, de Bakker PIW, Asselbergs FW, Srikanth V, Thomson R, McWhirter R, Moran C, Callisaya M, Phan T, Rutten-Jacobs LCA, Bevan S, Tzourio C, Mather KA, Sachdev PS, van Duijn CM, Worrall BB, Dichgans M, Kittner SJ, Markus HS, Ikram MA, Fornage M, Launer LJ, Seshadri S, Longstreth WT Jr, Debette S; Stroke Genetics Network (SiGN), the International Stroke Genetics Consortium (ISGC), METASTROKE, Alzheimer's Disease Genetics Consortium (ADGC), and the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Neurology. 2019 Jan 16. pii: 10.1212/WNL.0000000000006851. doi: 10.1212/WNL.0000000000006851. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center